Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
Public ClinicalTrials.gov record NCT00468767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Centred Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to demonstrate the effectiveness of RSD1235 in the conversion of atrial fibrillation to sinus rhythm.
Study identification
- NCT ID
- NCT00468767
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 356 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2003 (Type not available)
- Primary completion
- Nov 2004 (Actual)
- Completion
- Nov 2004 (Actual)
- Last update posted
- Apr 2, 2008
2003 – 2004
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California | Los Angeles | California | 90073 | — |
| Regional Cardiology Associates | Sacramento | California | 95819 | — |
| Florida Heart Institute | Orlando | Florida | 32803 | — |
| James Haley VA Hospital | Tampa | Florida | 33612 | — |
| Cardiac Arrhythmia Service, Massachusetts General Hospital | Boston | Massachusetts | 02459 | — |
| Thoracic and Cardiovascular Institute | Lansing | Michigan | 48910 | — |
| Oregon Health & Science University | Portland | Oregon | 97201 | — |
| Main Line Health Heart Center | Wynnewood | Pennsylvania | 19096 | — |
| Medical College of Virginia | Richmond | Virginia | 23219 | — |
| McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00468767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2008 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00468767 live on ClinicalTrials.gov.